NVAX logo

Novavax (NVAX) Depreciation and amortization

annual D&A:

$48.50M+$7.27M(+17.64%)
December 31, 2024

Summary

  • As of today (May 20, 2025), NVAX annual depreciation & amortization is $48.50 million, with the most recent change of +$7.27 million (+17.64%) on December 31, 2024.
  • During the last 3 years, NVAX annual D&A has risen by +$35.84 million (+283.03%).
  • NVAX annual D&A is now at all-time high.

Performance

NVAX Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

quarterly D&A:

$8.34M-$4.18M(-33.37%)
March 31, 2025

Summary

  • As of today (May 20, 2025), NVAX quarterly depreciation & amortization is $8.34 million, with the most recent change of -$4.18 million (-33.37%) on March 31, 2025.
  • Over the past year, NVAX quarterly D&A has dropped by -$3.81 million (-31.34%).
  • NVAX quarterly D&A is now -34.33% below its all-time high of $12.70 million, reached on September 30, 2024.

Performance

NVAX quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

TTM D&A:

$44.69M-$3.81M(-7.85%)
March 31, 2025

Summary

  • As of today (May 20, 2025), NVAX TTM depreciation & amortization is $44.69 million, with the most recent change of -$3.81 million (-7.85%) on March 31, 2025.
  • Over the past year, NVAX TTM D&A has increased by +$360.00 thousand (+0.81%).
  • NVAX TTM D&A is now -7.85% below its all-time high of $48.50 million, reached on December 31, 2024.

Performance

NVAX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

NVAX Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.6%-31.3%+0.8%
3 y3 years+283.0%+23.3%+161.2%
5 y5 years+754.4%+801.6%+858.6%

NVAX Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+283.0%-34.3%+24.1%-7.8%+161.2%
5 y5-yearat high+892.8%-34.3%+801.6%-7.8%+1102.3%
alltimeall timeat high>+9999.0%-34.3%+550.1%-7.8%+3495.8%

NVAX Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$8.34M(-33.4%)
$44.69M(-7.9%)
Dec 2024
$48.50M(+17.6%)
$12.52M(-1.4%)
$48.50M(+3.7%)
Sep 2024
-
$12.70M(+14.1%)
$46.77M(+3.0%)
Jun 2024
-
$11.13M(-8.4%)
$45.39M(+2.4%)
Mar 2024
-
$12.15M(+12.5%)
$44.33M(+7.5%)
Dec 2023
$41.23M(+41.9%)
$10.79M(-4.7%)
$41.23M(+9.5%)
Sep 2023
-
$11.32M(+12.5%)
$37.65M(+8.6%)
Jun 2023
-
$10.07M(+11.3%)
$34.68M(+10.7%)
Mar 2023
-
$9.04M(+25.2%)
$31.33M(+7.8%)
Dec 2022
$29.05M(+129.5%)
$7.22M(-13.5%)
$29.05M(+13.9%)
Sep 2022
-
$8.35M(+24.2%)
$25.50M(+19.1%)
Jun 2022
-
$6.72M(-0.7%)
$21.42M(+25.2%)
Mar 2022
-
$6.76M(+84.2%)
$17.11M(+35.1%)
Dec 2021
$12.66M(+159.2%)
$3.67M(-13.8%)
$12.66M(+17.4%)
Sep 2021
-
$4.26M(+76.8%)
$10.78M(+39.9%)
Jun 2021
-
$2.41M(+4.0%)
$7.71M(+22.8%)
Mar 2021
-
$2.32M(+29.2%)
$6.28M(+28.5%)
Dec 2020
$4.88M(-13.9%)
$1.79M(+51.3%)
$4.88M(+21.4%)
Sep 2020
-
$1.19M(+21.0%)
$4.02M(+8.2%)
Jun 2020
-
$980.00K(+5.9%)
$3.72M(-20.3%)
Mar 2020
-
$925.00K(-0.8%)
$4.66M(-17.9%)
Dec 2019
$5.68M(-30.4%)
$932.00K(+5.9%)
$5.68M(-15.6%)
Sep 2019
-
$880.00K(-54.3%)
$6.73M(-14.7%)
Jun 2019
-
$1.93M(-0.7%)
$7.89M(-1.6%)
Mar 2019
-
$1.94M(-2.2%)
$8.02M(-1.7%)
Dec 2018
$8.16M(-16.9%)
$1.98M(-2.9%)
$8.16M(-1.7%)
Sep 2018
-
$2.04M(-0.8%)
$8.30M(-15.2%)
Jun 2018
-
$2.06M(-1.1%)
$9.79M(+0.0%)
Mar 2018
-
$2.08M(-2.0%)
$9.79M(-0.3%)
Dec 2017
$9.82M(+15.4%)
$2.12M(-39.9%)
$9.82M(-1.0%)
Sep 2017
-
$3.53M(+71.6%)
$9.91M(+15.2%)
Jun 2017
-
$2.06M(-2.6%)
$8.61M(-0.6%)
Mar 2017
-
$2.11M(-4.8%)
$8.66M(+1.8%)
Dec 2016
$8.51M(+42.2%)
$2.22M(-0.1%)
$8.51M(+7.3%)
Sep 2016
-
$2.22M(+5.2%)
$7.92M(+9.2%)
Jun 2016
-
$2.11M(+8.1%)
$7.25M(+9.4%)
Mar 2016
-
$1.95M(+19.4%)
$6.63M(+10.8%)
Dec 2015
$5.98M(+35.2%)
$1.64M(+5.4%)
$5.98M(+3.6%)
Sep 2015
-
$1.55M(+4.4%)
$5.78M(+9.7%)
Jun 2015
-
$1.49M(+13.5%)
$5.26M(+10.7%)
Mar 2015
-
$1.31M(-8.4%)
$4.75M(+7.4%)
Dec 2014
$4.42M(+70.7%)
$1.43M(+37.5%)
$4.42M(+12.0%)
Sep 2014
-
$1.04M(+6.5%)
$3.95M(+10.2%)
Jun 2014
-
$976.00K(-0.4%)
$3.59M(+14.9%)
Mar 2014
-
$980.00K(+2.6%)
$3.12M(+20.5%)
Dec 2013
$2.59M(+55.5%)
$955.00K(+41.5%)
$2.59M(+24.2%)
Sep 2013
-
$675.00K(+31.8%)
$2.09M(+14.8%)
Jun 2013
-
$512.00K(+14.0%)
$1.82M(+6.2%)
Mar 2013
-
$449.00K(-0.2%)
$1.71M(+2.7%)
Dec 2012
$1.67M(+3.3%)
$450.00K(+10.8%)
$1.67M(+2.1%)
Sep 2012
-
$406.00K(0.0%)
$1.63M(-0.2%)
Jun 2012
-
$406.00K(+0.5%)
$1.64M(+0.4%)
Mar 2012
-
$404.00K(-2.9%)
$1.63M(+0.9%)
Dec 2011
$1.61M(+17.6%)
$416.00K(+1.7%)
$1.61M(+2.2%)
Sep 2011
-
$409.00K(+2.5%)
$1.58M(+3.3%)
Jun 2011
-
$399.00K(+2.6%)
$1.53M(+4.2%)
Mar 2011
-
$389.00K(+2.1%)
$1.47M(+6.8%)
Dec 2010
$1.37M
$381.00K(+6.4%)
$1.37M(+6.7%)
DateAnnualQuarterlyTTM
Sep 2010
-
$358.00K(+6.2%)
$1.29M(+5.0%)
Jun 2010
-
$337.00K(+13.9%)
$1.23M(+2.4%)
Mar 2010
-
$296.00K(+0.3%)
$1.20M(+0.2%)
Dec 2009
$1.19M(+33.7%)
$295.00K(-0.7%)
$1.19M(-1.4%)
Sep 2009
-
$297.00K(-3.6%)
$1.21M(+31.6%)
Jun 2009
-
$308.00K(+4.8%)
$920.00K(-5.9%)
Mar 2009
-
$294.00K(-5.8%)
$978.00K(+9.5%)
Dec 2008
$893.00K(+7.1%)
$312.00K(+5100.0%)
$893.00K(+7.3%)
Sep 2008
-
$6000.00(-98.4%)
$832.00K(-29.3%)
Jun 2008
-
$366.00K(+75.1%)
$1.18M(-20.2%)
Mar 2008
-
$209.00K(-16.7%)
$1.47M(+76.6%)
Dec 2007
$834.00K(+124.8%)
$251.00K(-28.3%)
$834.00K(-165.7%)
Sep 2007
-
$350.00K(-47.2%)
-$1.27M(-3.5%)
Jun 2007
-
$663.00K(-254.2%)
-$1.32M(+22.4%)
Mar 2007
-
-$430.00K(-76.8%)
-$1.07M(-389.8%)
Dec 2006
$371.00K(-79.3%)
-$1.85M(-709.5%)
$371.00K(-62.0%)
Sep 2006
-
$304.00K(-66.4%)
$976.00K(-40.7%)
Jun 2006
-
$904.00K(-11.0%)
$1.65M(-7.4%)
Mar 2006
-
$1.02M(-181.4%)
$1.78M(-0.6%)
Dec 2005
$1.79M(-41.4%)
-$1.25M(-228.1%)
$1.79M(-54.4%)
Sep 2005
-
$974.00K(-6.0%)
$3.93M(+4.4%)
Jun 2005
-
$1.04M(+0.9%)
$3.76M(+9.6%)
Mar 2005
-
$1.03M(+15.5%)
$3.43M(+12.4%)
Dec 2004
$3.05M(+157.4%)
$889.00K(+10.0%)
$3.05M(+23.3%)
Sep 2004
-
$808.00K(+14.1%)
$2.48M(+25.1%)
Jun 2004
-
$708.00K(+9.3%)
$1.98M(+27.3%)
Mar 2004
-
$648.00K(+107.7%)
$1.55M(+31.0%)
Dec 2003
$1.19M(+4.2%)
$312.00K(+0.3%)
$1.19M(+2.7%)
Sep 2003
-
$311.00K(+9.9%)
$1.16M(+2.7%)
Jun 2003
-
$283.00K(+1.1%)
$1.13M(+0.3%)
Mar 2003
-
$280.00K(-0.4%)
$1.12M(-1.4%)
Dec 2002
$1.14M(-67.4%)
$281.00K(0.0%)
$1.14M(-35.6%)
Sep 2002
-
$281.00K(+0.4%)
$1.77M(-24.6%)
Jun 2002
-
$280.00K(-5.4%)
$2.35M(-21.8%)
Mar 2002
-
$296.00K(-67.5%)
$3.00M(-14.0%)
Dec 2001
$3.49M(+487.4%)
$911.00K(+6.1%)
$3.49M(+21.9%)
Sep 2001
-
$859.00K(-8.1%)
$2.86M(+35.9%)
Jun 2001
-
$935.00K(+19.3%)
$2.11M(+65.1%)
Mar 2001
-
$784.00K(+175.1%)
$1.28M(+114.8%)
Dec 2000
$594.00K(+48.5%)
$285.00K(+176.7%)
$594.00K(+45.2%)
Sep 2000
-
$103.00K(-1.0%)
$409.00K(-19.2%)
Jun 2000
-
$104.00K(+2.0%)
$506.00K(+25.9%)
Mar 2000
-
$102.00K(+2.0%)
$402.00K(+0.5%)
Dec 1999
$400.00K(+33.3%)
$100.00K(-50.0%)
$400.00K(0.0%)
Sep 1999
-
$200.00K(>+9900.0%)
$400.00K(+33.3%)
Jun 1999
-
$0.00(-100.0%)
$300.00K(0.0%)
Mar 1999
-
$100.00K(0.0%)
$300.00K(0.0%)
Dec 1998
$300.00K(0.0%)
$100.00K(0.0%)
$300.00K(0.0%)
Sep 1998
-
$100.00K(>+9900.0%)
$300.00K(0.0%)
Jun 1998
-
$0.00(-100.0%)
$300.00K(0.0%)
Mar 1998
-
$100.00K(0.0%)
$300.00K(0.0%)
Dec 1997
$300.00K(0.0%)
$100.00K(0.0%)
$300.00K(0.0%)
Sep 1997
-
$100.00K(>+9900.0%)
$300.00K(+50.0%)
Jun 1997
-
$0.00(-100.0%)
$200.00K(-33.3%)
Mar 1997
-
$100.00K(0.0%)
$300.00K(0.0%)
Dec 1996
$300.00K
$100.00K(>+9900.0%)
$300.00K(+50.0%)
Sep 1996
-
$0.00(-100.0%)
$200.00K(0.0%)
Jun 1996
-
$100.00K(0.0%)
$200.00K(+100.0%)
Mar 1996
-
$100.00K
$100.00K

FAQ

  • What is Novavax annual depreciation & amortization?
  • What is the all time high annual D&A for Novavax?
  • What is Novavax annual D&A year-on-year change?
  • What is Novavax quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Novavax?
  • What is Novavax quarterly D&A year-on-year change?
  • What is Novavax TTM depreciation & amortization?
  • What is the all time high TTM D&A for Novavax?
  • What is Novavax TTM D&A year-on-year change?

What is Novavax annual depreciation & amortization?

The current annual D&A of NVAX is $48.50M

What is the all time high annual D&A for Novavax?

Novavax all-time high annual depreciation & amortization is $48.50M

What is Novavax annual D&A year-on-year change?

Over the past year, NVAX annual depreciation & amortization has changed by +$7.27M (+17.64%)

What is Novavax quarterly depreciation & amortization?

The current quarterly D&A of NVAX is $8.34M

What is the all time high quarterly D&A for Novavax?

Novavax all-time high quarterly depreciation & amortization is $12.70M

What is Novavax quarterly D&A year-on-year change?

Over the past year, NVAX quarterly depreciation & amortization has changed by -$3.81M (-31.34%)

What is Novavax TTM depreciation & amortization?

The current TTM D&A of NVAX is $44.69M

What is the all time high TTM D&A for Novavax?

Novavax all-time high TTM depreciation & amortization is $48.50M

What is Novavax TTM D&A year-on-year change?

Over the past year, NVAX TTM depreciation & amortization has changed by +$360.00K (+0.81%)
On this page